Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1352 publications
US Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 4,000.00

This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R& ...

136 pages
UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,600.00

This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R& ...

124 pages
Spain Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,950.00

This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

128 pages
Japan Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 3,000.00

This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

129 pages
Italy Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,500.00

This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

125 pages
Germany Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,950.00

This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

128 pages
France Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 3,200.00

This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

100 pages
Europe Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 6,000.00

This unique report from Venture Planning Group provides Europe sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

151 pages
Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 9,200.00

This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of cancer diagnostic testing ... presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

174 pages
EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 US$ 3,995.00

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 SUMMARY Breast cancer is a malignant tumor that originates in the breast tissues. ... historical data obtained from the WHO International Agency for Cancer Research’s (IARC’s) SurvCan, the Surveillance of Epidemiology and End Results ...

Sep, 2014 70 pages
Global Non-small Cell Lung Cancer Market 2014-2018 US$ 2,500.00

... cell (undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go ... , shortness of breath, and wheezing. TechNavio's analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 3.62 percent over the period ...

Sep, 2014 92 pages
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide US$ 1,490.00

... . This is our 4th report on Cancer Sector. Renub Research study titled “Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide” analyzes the ... through 2018. A six year historic analysis is also provided for these markets. This 258 page report with 252 Figures and 14 Tables ...

Sep, 2014 258 pages
Global Cancer Vaccines Market & Pipeline Analysis US$ 2,400.00

... present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into ... Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for ...

Sep, 2014 864 pages
Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids US$ 3,016.00

... are based on 'real world' market data. Recent years have seen the rapid development of minimally invasive diagnostic techniques in the cancer field, notably so- ... they are providing, into tests that impact on clinical care or which drive new discovery. The current studies profiled more than 855 experienced ...

Sep, 2014 170 pages
The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth US$ 900.00

... growth rate can be attributed to an increasing number of drugs being approved by the United States Food and Drug Association along with the increasing ... held a market share of ~% and recorded sales of USD ~ million. The US Anti Cancer Drug Market is expected to grow over the period at a CAGR of 29.4% with ...

Jul, 2014 144 pages
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 US$ 2,000.00

... trials studies have demonstrated the fact that the potential of peptide based drugs to prevent and eradicate cancer is far effective than conventional ... therapy, both conventional and peptide based cancer therapeutics are used for the treatment. “Global Peptide Cancer Therapeutics Market & Pipeline Insight ...

Aug, 2014 556 pages
Global Breast Cancer Market Report: 2014 Edition US$ 800.00

... . The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, ... faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel ...

Aug, 2014 65 pages
PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

... GlobalData's report 'PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022', provides comprehensive information on prostate cancer therapeutics, highlighting ... cancer patients, and how will this change over the forecast period? How will pipeline drugs attempt to meet these needs? ...

Nov, 2012 288 pages
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies US$ 3,900.00

... maintaining front line, product level access and education. In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord ... marketed and four pipeline products Examination of physicians’ current usage of Medical Affairs teams services Key findings regarding the most and ...

Aug, 2014 54 pages
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market US$ 4,995.00

... provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation ... most promising pipeline drugs. An epidemiological forecast of the major NSCLC markets, in which projected values include total and treated populations An in-depth ...

Jul, 2014 143 pages
Global Cancer Generics Market Outlook 2018 US$ 1,400.00

... growth. According to our latest research report “Global Cancer Generics Market Outlook 2018”, the global oncology market touched a mark of US$ 91 Billion in 2013 ... future incidences, regional analysis and patent expiration status of key cancer drugs. Analysis of key industry trends and drivers crucial to the ...

Aug, 2014 100 pages
Cancer Immunotherapy Market & Clinical Pipeline Insight US$ 3,000.00

... depending on the location. With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced ... is one of the major reasons for cancer immunotherapy not being in widespread use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: ...

Jul, 2014 1990 pages
Uterine Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Uterine Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2014 US$ 1,250.00

... Cancer) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed ... . Devise corrective measures for pipeline projects by understanding Transitional Cell Cancer (Urothelial Cell Cancer) pipeline depth and focus of Indication therapeutics ...

Aug, 2014
Thyroid Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Thyroid Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Thymus Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Thymus Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Testicular Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Testicular Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Testicular Cancer. This ...

Aug, 2014
Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Squamous Non-Small Cell Lung Cancer pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Skin Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Skin Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Recurrent Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014 US$ 1,250.00

... The report provides a snapshot of the global therapeutic landscape of Recurrent Head And Neck Cancer Squamous Cell Carcinoma The report provides pipeline ... and complete understanding over therapeutics development for Recurrent Head And Neck Cancer Squamous Cell Carcinoma Identify the relationship between the ...

Aug, 2014
Peritoneal Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Peritoneal Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peritoneal Cancer. This ...

Aug, 2014
Pediatric Cancer-Pipeline Insights, 2014 US$ 1,250.00

... SUMMARY DelveInsight’s,“ Pediatric Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Papillary Thyroid Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Papillary Thyroid Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Other Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Other Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014 US$ 1,250.00

... information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, ... . Devise corrective measures for pipeline projects by understanding Non Muscle Invasive Bladder Cancer (NMIBC) pipeline depth and focus of Indication therapeutics ...

Aug, 2014
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014 US$ 1,250.00

... information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, ... a snapshot of the global therapeutic landscape of Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) The report provides pipeline products ...

Aug, 2014
Nasopharyngeal Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Nasopharyngeal Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Nasopharyngeal Cancer. This report provides ...

Aug, 2014
Metastatic Renal Cell Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Renal Cell Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Prostate Cancer-Pipeline Insights, 2014 US$ 1,250.00

... SUMMARY DelveInsight’s,“ Metastatic Prostate Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Ovarian Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Ovarian Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Lung Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Lung Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Liver Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Liver Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014 US$ 1,250.00

... Cancer dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed ... , development partner and chemical information Coverage of the Metastatic Hormone Refractory Prostate Cancer pipeline on the basis of target, MOA, route of administration ...

Aug, 2014
Medullary Thyroid Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Medullary Thyroid Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Human papillomavirus (HPV) Associated Cancer-Pipeline Insights, 2014 US$ 1,250.00

... the understanding for all the pipeline drugs that fall under Human papillomavirus (HPV) Associated Cancer. This report provides information ... , development partner and chemical information Coverage of the Human papillomavirus (HPV) Associated Cancer pipeline on the basis of target, MOA, route of administration ...

Aug, 2014
Hormone Refractory Breast Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Hormone Refractory Breast Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014 US$ 1,250.00

... The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer Squamous Cell Carcinoma The report provides pipeline products ... . Devise corrective measures for pipeline projects by understanding Head And Neck Cancer Squamous Cell Carcinoma pipeline depth and focus of Indication ...

Aug, 2014
Gynecological Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Gynecological Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Gynecological Cancer. ...

Aug, 2014
Gastrointestinal Tract Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Gastrointestinal Tract Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Gastrointestinal ...

Aug, 2014
Gallbladder Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Gallbladder Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Gallbladder Cancer. ...

Aug, 2014
1 2 3 4 5 >
Skip to top